14 Aug
RSV can be serious in adults 60+. Research studies enrolling.
Alabama, Birmingham 00000 Birmingham USA

If you or a loved one are 60+, Respiratory Syncytial Virus (RSV) infections can be severe. Investigational research could lead to the development of a vaccine. Right now, area doctors are looking for older adults to join clinical trials. See if you may be eligible. NOTE: The RSV study vaccine does not interfere with any available COVID vaccines.

Get Started Now




For more information, visit StudiesforRSVvaccine.com

Those who qualify may receive:

Payment from $875 to $1,325 which varies by study

No-cost study-related care from local doctors

No-cost study medication

Plus, no health insurance is needed!

About Acurian:

Acurian is a company that recruits people for clinical research studies. We are currently working with pharmaceutical companies to find individuals who are willing to participate in clinical research studies in your area.

In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.

Related jobs

Report job